NeuroSense Therapeutics (NRSN) Competitors $0.95 -0.04 (-4.05%) (As of 02:30 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NRSN vs. BGM, VIRI, RFL, ITRM, IOBT, IMMX, STTK, VTVT, CALC, and NBRVShould you be buying NeuroSense Therapeutics stock or one of its competitors? The main competitors of NeuroSense Therapeutics include Qilian International Holding Group (BGM), Virios Therapeutics (VIRI), Rafael (RFL), Iterum Therapeutics (ITRM), IO Biotech (IOBT), Immix Biopharma (IMMX), Shattuck Labs (STTK), vTv Therapeutics (VTVT), CalciMedica (CALC), and Nabriva Therapeutics (NBRV). These companies are all part of the "pharmaceutical preparations" industry. NeuroSense Therapeutics vs. Qilian International Holding Group Virios Therapeutics Rafael Iterum Therapeutics IO Biotech Immix Biopharma Shattuck Labs vTv Therapeutics CalciMedica Nabriva Therapeutics Qilian International Holding Group (NASDAQ:BGM) and NeuroSense Therapeutics (NASDAQ:NRSN) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, community ranking, dividends, risk, institutional ownership, profitability and valuation. Which has more risk and volatility, BGM or NRSN? Qilian International Holding Group has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, NeuroSense Therapeutics has a beta of 1.58, suggesting that its share price is 58% more volatile than the S&P 500. Does the MarketBeat Community prefer BGM or NRSN? NeuroSense Therapeutics received 2 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. CompanyUnderperformOutperformQilian International Holding GroupN/AN/ANeuroSense TherapeuticsOutperform Votes2100.00% Underperform VotesNo Votes Do institutionals & insiders believe in BGM or NRSN? 1.0% of NeuroSense Therapeutics shares are held by institutional investors. 58.7% of Qilian International Holding Group shares are held by insiders. Comparatively, 27.4% of NeuroSense Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is BGM or NRSN more profitable? Company Net Margins Return on Equity Return on Assets Qilian International Holding GroupN/A N/A N/A NeuroSense Therapeutics N/A N/A -286.31% Which has stronger valuation & earnings, BGM or NRSN? Qilian International Holding Group has higher revenue and earnings than NeuroSense Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQilian International Holding Group$46.47M1.09-$7.78MN/AN/ANeuroSense TherapeuticsN/AN/A-$11.28M-$0.85-1.12 Does the media favor BGM or NRSN? In the previous week, Qilian International Holding Group and Qilian International Holding Group both had 1 articles in the media. NeuroSense Therapeutics' average media sentiment score of 0.64 beat Qilian International Holding Group's score of 0.00 indicating that NeuroSense Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qilian International Holding Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeuroSense Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryQilian International Holding Group and NeuroSense Therapeutics tied by winning 4 of the 8 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get NeuroSense Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NRSN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRSN vs. The Competition Export to ExcelMetricNeuroSense TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.99M$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E Ratio-1.125.5695.6214.26Price / SalesN/A371.591,217.1987.73Price / CashN/A52.5939.5936.27Price / Book-6.7910.236.946.36Net Income-$11.28M$153.22M$118.89M$225.56M7 Day Performance-26.92%-1.36%-1.33%-0.10%1 Month Performance-13.64%-6.81%-3.17%2.02%1 Year Performance82.76%32.27%32.49%27.87% NeuroSense Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRSNNeuroSense Therapeutics0.6395 of 5 stars$0.95-4.1%N/A+92.7%$12.99MN/A-1.1218Upcoming EarningsBGMQilian International Holding GroupN/A$7.00+2.9%N/AN/A$50.61M$46.47M0.00298Gap UpVIRIVirios Therapeutics0.741 of 5 stars$2.60+40.5%$3.00+15.4%+254.9%$50.07MN/A-9.635Gap DownRFLRafael0.596 of 5 stars$2.02+3.6%N/A+8.3%$49.83M$640,000.000.0013ITRMIterum Therapeutics2.064 of 5 stars$1.78+8.9%$5.00+181.7%+18.1%$48.85MN/A0.0010Gap UpIOBTIO Biotech3.3225 of 5 stars$0.74-10.1%$9.33+1,165.0%-16.3%$48.61MN/A-0.5330High Trading VolumeIMMXImmix Biopharma2.2953 of 5 stars$1.76-3.3%$7.00+297.7%-58.7%$48.42MN/A0.009Negative NewsSTTKShattuck Labs2.8317 of 5 stars$1.00-9.9%$8.67+766.7%-50.7%$47.74M$1.66M0.00100Analyst RevisionVTVTvTv Therapeutics0.3302 of 5 stars$15.41-0.3%N/A+10.4%$46.38M$2.02M-3.419CALCCalciMedica3.0928 of 5 stars$3.44-0.3%$19.33+462.0%+10.6%$46.37MN/A0.0030NBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M-0.0739Analyst ForecastNews Coverage Related Companies and Tools Related Companies BGM Competitors VIRI Competitors RFL Competitors ITRM Competitors IOBT Competitors IMMX Competitors STTK Competitors VTVT Competitors CALC Competitors NBRV Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NRSN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroSense Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroSense Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
